TrialJAMA psychiatry2025

ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression: The ENLIGHTEN Randomized Clinical Trial.

Gang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.